IRIS
AMBROSIO, Maria Rosaria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9379
EU - Europa 4306
AS - Asia 1531
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 5
AF - Africa 1
OC - Oceania 1
Totale 15229
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9367
DE - Germania 1808
CN - Cina 1090
UA - Ucraina 803
IT - Italia 500
TR - Turchia 416
RU - Federazione Russa 306
GB - Regno Unito 266
SE - Svezia 192
FI - Finlandia 191
PL - Polonia 145
FR - Francia 48
BE - Belgio 22
CA - Canada 9
VN - Vietnam 8
EU - Europa 6
RO - Romania 6
IE - Irlanda 5
IN - India 5
NL - Olanda 5
IR - Iran 4
MX - Messico 3
CH - Svizzera 2
EC - Ecuador 2
ES - Italia 2
JP - Giappone 2
AT - Austria 1
AU - Australia 1
BD - Bangladesh 1
BR - Brasile 1
CY - Cipro 1
DK - Danimarca 1
GR - Grecia 1
KR - Corea 1
MA - Marocco 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
VE - Venezuela 1
Totale 15229
Salva come PNG Salva come JPEG
Città #
Woodbridge 1316
Fairfield 1155
Chandler 1111
Jacksonville 897
Houston 767
Ann Arbor 506
Ashburn 448
Wilmington 442
Seattle 428
Cambridge 359
Izmir 278
Beijing 268
Nanjing 263
Princeton 226
Addison 216
San Diego 152
Warsaw 145
Ferrara 127
Milan 120
Boardman 107
Shenyang 78
Hebei 70
Nanchang 70
Bremen 66
Dearborn 56
Changsha 46
Mountain View 46
Tianjin 46
Jiaxing 43
Falls Church 37
Washington 36
Redwood City 35
Jinan 31
Kunming 30
Ningbo 24
Norwalk 23
Brussels 22
Helsinki 22
Guangzhou 19
Des Moines 18
San Mateo 18
London 17
Zhengzhou 17
Orange 15
Auburn Hills 14
Taizhou 12
Hangzhou 11
Indiana 11
Hefei 10
Los Angeles 10
New York 10
Bologna 9
Carrara 9
Philadelphia 9
Dong Ket 8
Leawood 8
Monmouth Junction 8
Haikou 7
Lanzhou 7
Augusta 6
Changchun 6
Redmond 6
Castelnuovo Rangone 5
Chicago 5
Verona 5
Walnut 5
Ardabil 4
Dallas 4
Ferrara di Monte Baldo 4
San Francisco 4
Shanghai 4
Stockholm 4
Toronto 4
Cordovado 3
Fuzhou 3
Jinhua 3
Napoli 3
Paris 3
Voghera 3
Amsterdam 2
Andover 2
Bollate 2
Brembate 2
Chengdu 2
Cuauhtémoc 2
Mereto Di Tomba 2
Mumbai 2
Munich 2
Novara 2
Ottawa 2
Pescara 2
Quito 2
Xian 2
Yellow Springs 2
Alexandria 1
Alghero 1
Arzano 1
Aversa 1
Baltimore 1
Baotou 1
Totale 10479
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 225
Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man 151
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 148
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 142
Circadian profile of plasma calcitonin gene-related peptide in healthy man 136
Applicability of laparoscopic approach to the resection of large adrenal tumours: a retrospective cohort study on 200 patients 134
null 130
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion. 128
Circadian rhythm of calcitonin gene-related peptide in uncomplicated essential hypertension 127
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization 127
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 120
X-linked acrogigantism syndrome: clinical profile and therapeutic responses 119
null 118
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 117
Cerebral aneurysm and acromegaly: a case report 115
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 115
null 114
Evidence that enhancement of cholinergic tone increases basal plasma levels of calcitonin gene-related peptide in normal man 113
null 113
Pituitary side effects of old and new drugs. 113
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 113
null 111
In vitro testing of new somatostatin analogs on pituitary tumor cells 111
null 111
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 110
Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion. 109
null 108
Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI) 107
null 106
null 106
null 106
RET mutation profile and variable clinical manifestations in a family with multiple endocrine neoplasia type 2A and Hirschsprung's disease. 106
null 105
null 104
null 103
null 102
null 102
null 102
null 101
null 101
null 100
null 100
Chromogranin A as a marker of neuroendocrine neoplasia: an Italian Multicenter Study. 100
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 100
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 99
null 98
Growth hormone and skeletal muscle function 97
Growth hormone excess promotes breast cancer chemoresistance 97
null 97
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 96
Therapeutic concentrations of mitotane (o,p'-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model. 96
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 95
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 94
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 94
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 94
null 92
null 91
DELTA-OPIOID RECEPTOR MODULATION OF THE HYPOTHALAMIC -PITUITARY-ADRENOCORTICAL AXIS 90
Le alterazioni pressorie nell'acromegalia: fattori umorali 89
null 88
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 88
null 88
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 86
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 86
Diurnal rhythm of plasma catecholamines in acromegaly. 85
null 85
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 85
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 84
Growth hormone deficiency in succesfully treated acromegalic patients is not protective from cardiac complications 84
null 84
Growth hormone induces chemoresistance in breast cancer cells 84
Ovarian tumors secreting insulin 84
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 84
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 83
Prevalence of hypopituitarismin patients with cerebrovascular diseases 82
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 81
null 81
null 81
Glucose metabolism alterations in acromegaly 80
Acute lowering of plasma GH concentrations by somatostatin is associated with activation of pituitary-adrenal-axisin healthy young and elderly subjects 80
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 80
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 79
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 79
Pattern of Growth Hormone secretion in closed head injured patients 78
Real-world study of everolimus in advanced progressive neuroendocrine tumors 78
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 78
Systemic illness 77
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 77
Delta opioid receptor involvement in endocrine pathophysiology 76
Antiproliferative effects of somatostatin analogs in pituitary adenomas 76
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 76
Functional hypothalamic and drug-induced amenorrhea: an overview 76
Cerebrovascular disease and GH-IGF-i axis function 76
Occurrence of pituitary dysfunction following traumatic brain injury 75
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 75
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 75
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 75
A defective hypothalamic GHRH activity may contribute to declining GH secretion wuth age in man 75
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 75
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: effects of administration of epinephrine and norepinephrine in healthy man. 74
Totale 9841
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30274
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2424
Totale 32698
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018403 0000 00 00 1525411618
2018/20192639 114107110146 14728 35425 190334348736
2019/20203128 5479287447 184397 235308 21037519551
2020/20212021 187145119256 72212 64235 66269288108
2021/20221981 5820811457 8990 9690 79162187751
2022/20232129 23422190310 328341 131208 266000
Totale 15455